Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
CYBIN and Clarmin Announce Closing of CDN$45 Million Oversubscribed ...
Cybin Corp Announces Partnership with the Toronto Centre for ...
Cybin Pf Inj 100mg/ml in Mumbai, VHB Life Science Ltd. | ID: 9813191230
Cybin Corp: Developing Psychedelic Medicines and Nutraceutical Products ...
Cybin Inc. (NEO: CYBN) in Prime Position as Interest in Psychedelic ...
Cybin and Clinilabs Granted Schedule I DEA License for CYB003 Phase 1 ...
Cybin Therapeutics 2026 Company Profile: Valuation, Funding & Investors ...
Cybin Announces Approval of First-in-Human Dosing of its Proprietary ...
Ethical Biopharmaceutical Company Cybin Establishes Presence in St ...
Cybin has partnered with Worldwide Clinical Trials — a global, full ...
Cybin (CYBN.NE) Completes 51st Pre-Clinical Psychedelic Molecule Study ...
Cybin Announces Successful Completion of In Vivo Preclinical Studies ...
Cybin Engages Thermo Fisher for Phase 3 and Commercial Manufacturing of ...
Cybin Acquires DMT Clinical Study from Entheon Biomedical. The Phase 1 ...
Cybin Completes Dosing in Phase 2 Study of CYB003 for the Treatment of ...
Cybin Receives FDA Breakthrough Therapy Designation for its Novel ...
Cybin Announces Groundbreaking Clinical Progress, Unveiling ...
Cybin Announces First Patient Dosing in Psilocybin Depression Clinical ...
How Cybin Is 'Revolutionizing' Healthcare with Psychedelic Compounds
Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating ...
FDA Grants Cybin Breakthrough Therapy Designation for CYB003 - The ...
Cybin | Tendril
Extremely proud of how the Cybin Inc. team has been able to leverage an ...
Cilo Cybin Holdings Announces Acquisition of Cilo Cybin Pharmaceutical ...
Cybin Phase 3 Trial Advances as FDA Prioritizes Psychedelic Reviews ...
Cybin to Measure Psychedelic Effects on the Brain | Psychedelic Spotlight
Cybin Announces Unprecedented Positive Phase 2 Interim Data for CYB003 ...
Cybin Receives FDA Breakthrough Therapy Designation - Long Term Biotech ...
Cybin Gets FDA Approval For New Phase 2 Trial | Microdose
Cybin receives FDA approval for new in-human clinical trial ...
Cybin Raises $150M to Advance Psychedelic Therapy for Depression
Cybin - Changing Minds and leading ethical biopharmaceutical company ...
FDA Authorizes Cybin Device to Quantify Psychedelics’ Effects on the Brain
Cybin Announces Phase 2 Cohort 5 Dosing Completion of CYB003 in Major ...
Cybin Confirms Scientific Advice Meeting with UK Medical and Healthcare ...
Cybin Outlines Upcoming Priorities and Milestones for its Clinical ...
Cybin Corp. and IntelGenx Corp. Enter Into Feasibility Agreement for ...
Cybin reports positive results after CYB003 dose | Cybin Inc posted on ...
Cilo Cybin Holdings makes history at JSE | Cilo Cybin
Cybin Enters Definitive Agreement To Acquire Small Pharma | IBTimes
Cilo Cybin Holdings Sitting on R60m; Shareholders Now Waiting for the ...
Cybin Completes Reverse Take-Over Transaction | Psychedelic Finance
Cybin plans to run four clinical trials in 2024 | Cybin Inc posted on ...
Drysdale Explains $30m Cybin Shares Purchase Agreement - The Dales Report
Worldwide Clinical partners with Cybin for psychedelic-based treatments ...
Cybin (CYBN.NEO) approved for first-in-human dosing - Equity.Guru
Cybin Leads in Aligning with FDA's New Psychedelic Drugs Guidelines: A ...
Cybin Inc. Stock Overview — CYBN Summary & Analysis — Roic AI
Cybin Announces Positive Data Showing Effectiveness of Psilocybin To ...
Cybin Moves Forward With Market Strategies for Expansion Into ...
Cybin to Acquire Small Pharma Inc.
Cybin R&D Day: Innovating New Treatment Approaches for Mental ...
Cybin closes acquisition of Small Pharma | Cybin Inc posted on the ...
Cybin enrolls in CYB003 study | Cybin Inc posted on the topic | LinkedIn
Cybin Stock Analysis 2025 | Why CYBN Could Be the Future of Psychedelic ...
Cybin - 2026 Company Profile, Team, Funding & Competitors - Tracxn
Cybin Tackles Major Depressive Disorder with Psychedelic-Based ...
Join Cybin tomorrow at the 6th Annual Neuropsychiatric Drug Development ...
Cybin Announces Promising Results from Feasibility Study Measuring ...
Let's not forget about Cybin pipeline and the amazing team they have ...
Cybin Advances Psilocybin as Treatment for Depression and Addiction ...
Cybin ($CYBN) Announces Advancement in DMT Therapies with First Human ...
Cybin reaches end of psilocybin analogue clinical trial for depression ...
Catalent partners with Cybin for Fast-Dissolve Formulation CYB003
Cybin grants two U.S. patents for tryptamine-based drugs | Cybin Inc ...
Cybin Advances Breakthrough Mental Health Treatments with Key 2026 ...
Why Cybin Thinks This Novel Psilocybin Analog Is the 'Superior Molecule'
Cybin Stock In Focus On MDD Treatment's 'Breakthrough’ Efficacy: Retail ...
Cilo Cybin announces JSE main board entry - CNBC Africa
Cybin Inc: The Psychedelic Revolution in Mental Health Treatment is ...
El aumento semanal del 5,900 % de $DRUG llama la atención. Cybin ($CYBN ...
Cybin Reports First Quarter Fiscal Year 2025 Financial Results and ...
Cybin übernimmt Small Pharma Inc. - PharmaBarometer
Cybin Expands Clinical Team to Support CYB003 Phase 3 Program ...
Cybin Selects Anxiety Disorder Indications for Proprietary Psychedelic ...
Cybin Reports Recharged At-The-Market Equity Program
Cybin Announces Last Subject Dosed in Part B of its Phase 1 CYB004-E ...
Cybin Provides Corporate Update and Highlights Positive Regulatory ...
Cybin - LifeScienceHistory.com
Cybin Major Depressive Disorder Phase 2 | Nurse Sarah Barker
The Top Companies Leading Psilocybin Research & Therapy
List of Biotech, Pharmaceutical & Life Sciences companies in Canada
Cybin's CYB003 Receives UK Approval for Phase 3 Study on Depression ...
Cybin's Psilocybin Program Granted FDA Breakthrough Designation
julioviskovich - julioviskovich
UK Approves Cybin's Phase 3 Depression Treatment Trial Across 60 Global ...
Cybin: innovating the delivery of psychedelic therapy
Former Director of Psychiatric Products at FDA Joins Psychedelic Life ...
Psychedelic treatment breakthrough: Cybin’s CYB003 gives hope to ...
Paul F. Austin - Microdosing Psychedelics Coach
Psychedelic News Roundup: Half The World Faces Mental Health Crisis
Psychedelic Vantage | Covering Psychedelic Drug Development, Education ...
